INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Continuing my collaboration with Sasha Latypova this Wednesday

Continuing my collaboration with Sasha Latypova this Wednesday

It's going to be grrrrrreat!!!

Hedley Rees's avatar
Hedley Rees
Jul 25, 2022
∙ Paid
2

Share this post

INSIDE PHARMA
INSIDE PHARMA
Continuing my collaboration with Sasha Latypova this Wednesday
Share

Collaboration is the only way

It’s always been a guiding principle of mine that to achieve anything in life, it must be based on collaboration with others. Not just anyone of course—that’s another guiding principle—the collaborators must be on the same wavelength as you; and be willing to work with you.

Thankfully, Sasha Latypova and I share a wavelength and have been working together collaboratively for some time following the dreaded SARS-CoV-2 catastrophe.

This interview we did together is a sample of what’s to come on Wednesday this week:

INSIDE PHARMA
SASHA LATYPOVA'S FORENSIC INVESTIGATION INTO PFIZER'S 'FRADULENT' PRECLINICAL STUDIES
PFIZER DECIDED NOT TO DO PRECLINICAL STUDIES—NO OBJECTIONS RAISED! Sasha Latypova speaks to us on Pfizer’s sloppy, even fraudulent (Sasha’s words) work. She has been through Pfizer’s documents released under a FOIA. The documents are titled preclinical biodistribution studies…
Read more
3 years ago · 8 likes · 5 comments · Hedley Rees

Together, we have the pieces of the puzzle

When you put Sasha’s and my skill-sets together, setting modesty aside for the moment, we are a potent weapon in the fight against genetic vaccines, and the ‘irregularities’ that went on.

On Wednesday, I will be speaking to Sasha about how Pfizer cut corners to get the early batches of SARS-CoV-2 injections into the market; also, the damage these batches caused.

[The interview will form part of the evidence we are building in anticipation of a legal challenge in the not-too-distant future].

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share